7 months ago
SLNO
AnalystsKristen KluskaKristen Kluska's Stock Forecasts
AnalystsKristen Kluska
Sectors:
Analyst Ranking
Top 2%
#47 out of 4579 analysts
Average Return
+46.52%
Win Rate
44%50 out of 113
Risk vs Reward
Poor
Good
Kristen Kluska's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Ocugen IncOCGN | +2,480.06% | $0.36 | $9.19 | 2020-10-09 - 2021-05-07 | Strong Buy |
Soleno Therapeutics IncSLNO | +874.23% | $4.89 | $47.64 | 2023-07-11 - 2024-05-09 | Strong Buy |
Soleno Therapeutics IncSLNO | +874.23% | $4.89 | $47.64 | 2023-08-31 - 2024-05-09 | Strong Buy |
Celldex Therapeutics IncCLDX | +808.47% | $3.07 | $27.89 | 2020-02-21 - 2021-02-19 | Strong Buy |
Taysha Gene Therapies IncTSHA | +296.41% | $0.72 | $2.87 | 2023-03-30 - 2024-03-28 | Strong Buy |
Kristen Kluska Analyst Color
Get additional color on Kristen Kluska's coverage of popular stocks
9 months ago
TSHA
a year ago
IRON
a year ago
CBAY
a year ago
ETNB
a year ago
ETNB
a year ago
CBAY
2 years ago
ABEO
Kristen Kluska's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ultragenyx Pharmaceutical IncRARE | 7 | Strong Buy | $107.00 | +159.58% | Reiterates | 7 days ago |
Sarepta Therapeutics IncSRPT | 9 | Hold | $128.00 | -3.25% | Reiterates | 8 days ago |
Taysha Gene Therapies IncTSHA | 10 | Strong Buy | $7.00 | +176.68% | Reiterates | 10 days ago |
Actinium Pharmaceuticals IncATNM | 3 | Strong Buy | $21.00 | +135.96% | Reiterates | 10 days ago |
Abeona Therapeutics IncABEO | 5 | Strong Buy | $36.00 | +708.99% | Reiterates | 17 days ago |
Ptc Therapeutics IncPTCT | 10 | Strong Buy | $45.00 | +44.93% | Reiterates | a month ago |
89bio IncETNB | 7 | Strong Buy | $29.00 | +218.33% | Reiterates | a month ago |
Humacyte IncHUMA | 5 | Strong Buy | $7.00 | +54.87% | Reiterates | a month ago |
Mereo Biopharma Group PLCMREO | 4 | Strong Buy | $7.00 | +114.07% | Reiterates | a month ago |
Celldex Therapeutics IncCLDX | 7 | Strong Buy | $67.00 | +63.18% | Reiterates | 2 months ago |
Rigel Pharmaceuticals IncRIGL | 2 | Hold | $3.00 | +194.12% | Maintains | 2 months ago |
Adma Biologics IncADMA | 4 | Strong Buy | $8.00 | +15.44% | Maintains | 2 months ago |
Amicus Therapeutics IncFOLD | 3 | Strong Buy | $22.00 | +132.07% | Reiterates | 2 months ago |
Cymabay Therapeutics IncCBAY | 6 | Hold | $32.50 | +0.06% | Downgrades | 3 months ago |
Lineage Cell Therapeutics IncLCTX | 3 | Strong Buy | $6.00 | +408.47% | Reiterates | 3 months ago |
Capricor Therapeutics IncCAPR | 1 | Strong Buy | $8.00 | +47.60% | Initiates Coverage On | 4 months ago |
Uniqure NvQURE | 2 | Strong Buy | $21.00 | +314.20% | Reiterates | 5 months ago |
Disc Medicine IncIRON | 3 | Strong Buy | $85.00 | +176.24% | Reiterates | 5 months ago |
Soleno Therapeutics IncSLNO | 3 | Strong Buy | $35.00 | -26.53% | Maintains | 7 months ago |
Outlook Therapeutics IncOTLK | 2 | Hold | $20.00 | +158.73% | Downgrades | 8 months ago |
Alpha Tau Medical LtdDRTS | 2 | Strong Buy | $23.00 | +831.17% | Reiterates | 8 months ago |
Mustang Bio IncMBIO | 1 | Strong Buy | $18.00 | +6,566.67% | Reiterates | 9 months ago |
Ocuphire Pharma IncOCUP | 3 | Strong Buy | $17.00 | +767.35% | Reiterates | 9 months ago |
Durect CorpDRRX | 2 | Strong Buy | $41.00 | +3,528.32% | Maintains | 9 months ago |
X4 Pharmaceuticals IncXFOR | 2 | Strong Buy | $3.00 | N/A | Maintains | a year ago |
Galecto IncGLTO | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | a year ago |
Ibio IncIBIO | 3 | Hold | $85.00 | N/A | Downgrades | 2 years ago |
Sio Gene Therapies IncSIOX | 1 | Hold | $0.80 | N/A | Downgrades | 2 years ago |
Hepion Pharmaceuticals IncHEPA | 1 | Strong Buy | $70.00 | N/A | Initiates Coverage On | 2 years ago |
Eterna Therapeutics IncERNA | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | 2 years ago |
Evelo Biosciences IncEVLO | 1 | Strong Buy | $560.00 | N/A | Initiates Coverage On | 3 years ago |
Chemomab Therapeutics LtdCMMB | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | 3 years ago |
Ocugen IncOCGN | 3 | Hold | $11.00 | N/A | Downgrades | 3 years ago |
Marker Therapeutics IncMRKR | 2 | Strong Buy | $60.00 | N/A | Initiates Coverage On | 3 years ago |
Evogene LtdEVGN | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | 3 years ago |
Applied Genetic Technologies CorpAGTC | 1 | Strong Buy | $14.00 | N/A | Initiates Coverage On | 4 years ago |
Taiwan Liposome Company LtdTLC | 2 | Strong Buy | $10.00 | N/A | Reiterates | 4 years ago |
Galmed Pharmaceuticals LtdGLMD | 2 | Strong Buy | $210.00 | N/A | Assumes | 4 years ago |
Biomx IncPHGE | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.